Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-008246

Chief Scientific Officer sold 7,790 shares at an average $59.58 ($464,158)

  • Chief Scientific Officer acquired 7,790 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2021-02-03 Option exercise +7,790 $6.32 $49,233 8,469 D: show line 1 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-02-03 Sale −6,930 $59.49 $412,266 1,539 D: show line 2 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-02-03 Sale −860 $60.34 $51,892 679 D: show line 3 in the form
Open-market sales · 7,790 sh · avg $59.58 · $464,158

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2021-02-03 Option exercise · Stock Option (Right to Buy) −7,790 186,960 D: show line 4 in the form
Loading xslF345X03/doc4.xml…